Starling Oncology to Participate in Wells Fargo Healthcare Conference

Rhea-AI Summary

Starling Oncology (NASDAQ: STLN) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the Wells Fargo Healthcare Conference in Boston on Tuesday, September 8, 2026. Their appearance will include a fireside chat scheduled from 4:30–5:05 p.m. ET, with a webcast available via the Investor Relations section of the company’s website.

News Market Reaction – STLN

-5.18%

11 alerts

-5.18% Session close to close

$631.88M Market Cap

1.0x Rel. Volume

In the Aug 24 session, STLN declined 5.18%, reflecting a notable negative market reaction. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.2% in the session following this news. The prior Starling Nexus announcement was ...

Analysis

The stock moved -5.2% in the session following this news. The prior Starling Nexus announcement was followed by a -2.17% 24-hour move. A strong negative response to this conference notice would contrast with the prior earnings reaction, while the absence of reported metrics leaves disclosure depth as a risk.

Key Figures

Conference date: September 8, 2026 Fireside chat time: 4:30–5:05 p.m. ET

2 metrics

Conference date September 8, 2026 Wells Fargo Healthcare Conference in Boston

Fireside chat time 4:30–5:05 p.m. ET Wells Fargo Healthcare Conference

Historical Context

2 past events · Latest: Aug 17 (Positive)

Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 17	technology platform launch	Positive	-2.2%	Starling Nexus launch was followed by a negative 24-hour price reaction.
Aug 06	Q2 earnings report	Positive	+28.5%	Q2 results and raised full-year guidance were followed by a positive price reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent announcements showed mixed price reactions: Starling Nexus was followed by -2.17%, while Q2 earnings were followed by +28.46%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Wells Fargo Healthcare Conference, being held in Boston on Tuesday, September 8, 2026, including a fireside chat from 4:30–5:05 p.m. ET.

A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.starlingoncology.com/.

About Starling Oncology, Inc.

Founded in 2007, Starling Oncology, Inc. (Nasdaq: STLN) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Formerly known as The Oncology Institute, Starling Oncology offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, Starling Oncology is coordinating cancer care for the better. For more information visit www.starlingoncology.com. Please follow us on LinkedIn, X (formerly Twitter), or Bluesky.

Contacts

Media
ICR Healthcare
StarlingPR@icrhealthcare.com 

Investors
ICR Healthcare
StarlingIR@icrhealthcare.com 

FAQ

When will Starling Oncology (NASDAQ: STLN) appear at the Wells Fargo Healthcare Conference 2026?

Starling Oncology is scheduled to participate on Tuesday, September 8, 2026. According to Starling Oncology, the event will be held in Boston and will feature company leadership in a fireside chat during the conference schedule.

What time is Starling Oncology's fireside chat at the Wells Fargo Healthcare Conference on September 8, 2026?

Starling Oncology’s fireside chat is set for 4:30–5:05 p.m. ET on September 8, 2026. According to Starling Oncology, both CEO Dr. Daniel Virnich and CFO Rob Carter are expected to participate in this session.

How can investors access the Starling Oncology (STLN) webcast from the Wells Fargo Healthcare Conference?

Investors can access the webcast through the Investor Relations section of Starling Oncology’s website. According to Starling Oncology, a specific webcast link for the conference presentation will be made available at https://investors.starlingoncology.com/.

Who from Starling Oncology will present at the Wells Fargo Healthcare Conference 2026?

Starling Oncology will be represented by CEO Dr. Daniel Virnich and CFO Rob Carter. According to Starling Oncology, both executives will participate in the Boston conference, including a scheduled fireside chat session.

What is the significance of Starling Oncology’s participation in the Wells Fargo Healthcare Conference for STLN investors?

Participation provides a forum for management to communicate directly with institutional investors. According to Starling Oncology, its CEO and CFO will discuss the business during a webcast fireside chat, offering additional visibility and access to investor questions.